Investor directory

Proxima Ventures

Proxima Ventures is a venture capital firm based in Shanghai, China, founded in 2015. The firm specializes in angel, seed, and growth stage investments, primarily focusing on the healthcare industry. Proxima Ventures invests in a range of sectors, including disruptive biotechnologies, therapies, medical equipment, diagnostic techniques, digital healthcare solutions, and advanced medical data analysis platforms. In 2022, it managed the Suzhou Proxima RMB Fund III, further solidifying its commitment to building and growing next-generation healthcare companies.
http://www.proximavc.com
https://crunchbase.com/organization/proxima-ventures
https://pitchbook.com/profiles/investor/265654-90
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=534210137

Zhe Li

Co-Founder and Partner

Frankie Li

Associate Director

Sandra Sun

Managing Director

Jun Jie Yang

Partner

1 past transactions

ViewGene

Seed Round in 2022
ViewGene is a gene therapy company that has developed a proprietary inducible and tissue-specific gene therapy platform in China. The platform reduces the potential risks of uncontrollable dose and overexpression of gene expression and overcomes the shortcomings of traditional gene therapy techniques such as tissue destruction, immunogenicity, inflammatory response, and short onset time in vivo. The highlights of its gene therapy drugs are the clear dose-response relationship and high safety, which have significant advantages in the treatment of single-gene genetic diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.